Introduction
In all primate species studied, the embryo enters the uterus as a morula on Day 3^1 after ovulation, hatches from the zona pellucida on Days 6-8 and attaches to the endometrium on~D ays 7-9 (Old World species) or 11-12 (New World species). Implantation is highly invasive and interstitial in man and the apes, but relatively superficial in monkeys (simians) Hertig & Rock, 1945; Hendrickx & Enders, 1980; Enders et ai, 1983; Moore et ai, 1985; Hearn & Summers, 1986; Smith et ai, 1987; Hearn et ai, 1988a, b, in press;  Enders, 1989) . Therefore, the morphology of implantation is now relatively well described for a few primate species, showing a similar general pattern, albeit with distinct species differences (Hearn, 1986) .
The regulation of implantation, monitored through endocrine changes in peripheral plasma, is well studied as is the function of the corpus luteum (Knobil, 1973; Ross, 1979; Auletta & Flint, 1988 ; Anderson & Hodgen, 1989; Stouffer el ai, 1989) . There is a clear primate pattern with dis¬ tinct species variations in timing and endocrine synchrony. Many questions remain to be answered concerning the timing of corpus luteum (CL) 'rescue' (Short, 1969 (Short, , 1979 , the extent of embryonic loss (Lenton et ai, 1988) , the regulation of receptor function, the autocrine or paracrine functions of oestrogens and progestagens in trophoblast or luteal tissues (Stouffer et ai, 1989) and the dependence of the CL on embryo-derived gonadotrophin.
In contrast, there is little knowledge of the cellular and molecular processes regulating the activation and sequential expression of genes controlling embryonic signals, the attachment of the embryo to the endometrial epithelium, the rapid invasion of trophoblast, the establishment of embryo-maternal vascular links and the initial maternal responses to implantation by the endo¬ metrium. For example, the genes for chorionic gonadotrophin (CG) are thought to be expressed only in primates, but the ontogeny of their expression is unknown, as is the possible role of this hormone in local interactions at the implantation site. Equid CG is now thought to be similar to equid LH, and the C terminal extensions of the ß subunit in primates and humans arose independently (Leigh & Stewart, 1990) . The difficulties in obtaining precise data on the genetic or biochemical processes at the embryo-maternal interface have been due to the scarcity of precisely timed material during a dynamic and rapidly changing series of events, the lack of suitable reagents and, in man, the ethical constraints attached to such studies. While preimplantation development is now well described through advances in human in-vitro fertilization (Edwards, 1985) , implantation in primates has yet to be studied in detail. Nevertheless, it is known from many studies of nonprimates that essential factors regulating implantation, endometrial receptivity and CL function in early pregnancy are distinct in primates from those in nonprimate species.
A greater understanding of these factors would advance our understanding of primate' implantation and would be relevant to the treatment of infertility, the regulation of fertility, the explanation of early embryonic loss and the improvement of reproductive and embryonic health. Recent progress in this field is reviewed in a volume edited by Yoshinaga & Mori (1989 (Tesarik, 1989) . It is now apparent (Surani et ai, 1990 ) that neither the male nor the female genome by itself is totipotential. Surani et al. (1990) (1988) The presence of the ß-subunit of CG was detected in 3 of seven 6-8 cell human embryos by in-situ hybridization (Bonduelle et ai, 1988 (Enders, 1989) , but, after the mature chorionic villi have formed, CG expression is restricted to the syncytiotrophoblast. The co-ordinated expression of both subunits for the secretion of biologically active CG, together with the timing of such secretion and its physiological role within the embryo, at the embryo-endometrial interface or in trophoblast penetration, have yet to be clarified.
Preimplantation embryonic signals
There is no lack ofcandidates for embryo-derived signals during preimplantation stages of pregnancy. They include early pregnancy factor (Morton et ai, 1977) , platelet-activating factor (O'Neill, 1985) , Schwangershaftsprotein (Sinosich et ai, 1985) , histamine-releasing factor (Cocchiara et ai, 1987) We examined the transient thrombocytopenia reported to be associated with preimplantation stages in mouse and man (O'Neill, 1985) . In studies of conception cycles in 10 marmoset monkeys with 6 nonpregnant controls, a transient thrombocytopenia of 15-30% was found in the circulating platelets during preimplantation stages of pregnancy to Day 8 after ovulation in 7 animals, at which stage the embryos were flushed from the uteri to confirm their presence (Hearn et ai, 1988b) . We also studied the effects of culture media, from either 5 individual preimplantation or 4 postattachment embryos in vitro, injecting (01 ml aliquots) into splenectomized mice using the bioassay system developed by O'Neill (1985) . A 15-30% reduction in circulating platelets resulted over the subsequent 12 h from all 5 preimplantation embryo cultures and from 3 of the 4 postattachment stages sampled, whereas 5 controls with culture fluid only showed no effects (Table 2) . This work supports the hypothesis of O'Neill (1985) that an embryo-derived preimplantation sig¬ nal, perhaps platelet-activating factor is associated with the preimplantation phase of embryonic development. In contrast to the results in mice (O'Neill, 1985) , in which the effect ceased to be detectable in peripheral plasma after implantation in vivo, perhaps because of neutralization by maternal factors, our preliminary studies of post-attachment embryos in vitro showed a maintenance of the effect when maternal influences were removed. More robust assays are required.
Platelet-activating factors (PAF) are potent inducers of vascular permeability. It is not known whether the embryo during the peri-implantation period is a direct source of PAF, or an indirect stimulus in its release. The function of PAF during oviducal or uterine stages of early embryonic development is also uncertain, but a recent report showed that PAF in the uterine stroma is released by the presence of a blastocyst in rabbits. Studies of cultured human luteal-phase endometrial, glandular epithelium and stromal cells showed low concentrations of PAF in normal cells; addition of oestradiol-17ß to the cultures had no effect on these concentrations, but oestradiol and progesterone increased PAF concentrations in a dose-dependent manner, indicating hormonal regulation of the stromal cell content of PAF (Harper et ai, 1989) . Potentially relevant to this interaction are the studies of Wang et ai (1989) using anti-idiotype of monoclonal antiprogesterone antibody in the mouse uterus before implantation, showing that antiprogesterone antibody binds to an antigen associated with luminal and glandular epithelia, which may locally inhibit the uterine uptake of progesterone and disrupt implantation.
In Rhesus monkeys (Marston et ai, 1977) , marmoset monkeys (Summers et ai, 1987) and in some human in-vitro fertilization practice, embryos at early tubai stages of development can be Data are pooled from two studies using a radioimmunoassay (Chambers & Hearn, 1979 ) and a bioassay (Hearn el ai, 1988a) for marmoset CG. Detection using RIA was 1-2 days before that for bioassay. First measurement in vitro was after attachment of embryos to the monolayer and the initiation of trophoblast outgrowth (Hearn et ai, 1988b) . Table 4 summarizes the first detectable secretion of CG in vivo in 20 conception cycles dated from the day of ovulation, Days 14-18 being the norm and suggesting at least a 4-day 'implantation window'. Variable rates of development of marmoset embryos were found when they were flushed from uteri on each day of precisely timed conception cycles (Summers et ai, 1987) , which showed implantation in this primate to commence on Day 11-12. Therefore, CG can be detected in the peripheral circulation 2-3 days after embryo attachment in vivo.
In the more controlled conditions of in-vitro studies, the first detectable secretion of CG in embryo cultures of 20 marmoset embryos, recovered as blastocysts on Day 8 after ovulation and cultured individually on marmoset fibroblast feeder cell monolayers for the next 10 days, are centred on the day of blastocyst hatching, but again there was at least a 4-day period when embryos could attach and begin trophoblastic outgrowth (Table 4 ). All of these embryos showed secretion of CG immediately after attachment (Fig. 1) , but CG using our bioassay system (Hearn et ai, 1988a) was not detectable in culture media before the day of attachment and the initiation of trophoblastic outgrowth. With the availability of improved reagent specificity, we are now examin¬ ing, first, the hatched blastocyst and then, in reverse sequence, the earlier stages, to probe for the location, expression sites and secretion of CG in the preimplantation embryo. (Hearn et ai, 1988a) (Hearn, 1976; . (Savio et ai, 1988; Sirois & Fortune, 1988) . Three waves of follicular growth observed in heifers in the present study as well as the sizes of the dominant follicles, CL, timing of regression of dominant follicles and CL are in agreement with the above reports.
The present study reveals that treatment of heifers with norgestomet at dioestrus (in the presence of CL) did not have any effect on the wave-like pattern of follicular growth, but, when the treatment was given at pro-oestrus (in the absence of CL), the dominant follicle present was main¬ tained for the duration of the treatment and there was no growth of medium or small follicles. These differences in follicular dynamics could be due to changes in the secretory pattern of LH. Sirois et ai (1989) also reported prolonged maintenance of an ovulatory dominant follicle with the administration of low concentrations of progesterone. This implies that the norgestomet treatment given during pro-oestrus mimics the actions of low concentrations of progesterone. In cattle, administration of subnormal concentrations of progesterone has been shown to alter LH secretory pattern compared with animals receiving normal luteal concentrations (Ireland & Roche, 1982; Roberson et ai, 1989) . Roberson et al. (1989) also reported that the concentrations of oestradiol-17ß were higher and the onset of preovulatory surge was earlier in cows receiving subnormal pro¬ gesterone stimulation. This, according to our observation, may be related to the presence of an ovulatory follicle at progesterone withdrawal.
Two out of 8 heifers treated at pro-oestrus ovulated in spite of norgestomet treatment. This may be due to either insertion of the implant after the LH surge or insufficient norgestomet released from the implant to inhibit the LH surge. The fact that these 2 heifers had small CL at implant removal indicates that sufficient norgestomet was released to either suppress luteotrophic support (Ottobre, 1980; Battista et ai, 1984) or cause early luteal regression (Ottobre, 1980 , Garrett et ai, 1988 (Webley et ai, 1989) . Therefore, although the mean peripherally detected concentrations of CG were not significant until Day 17, the marmoset CL is apparently responding to a luteotrophic stimulus in the conception cycle by Day 14, which is within 2 days of attachment and before there is any morphologically distinct vascular connection (Smith et ai, 1987 
